Ss innovations conducts interactive meeting with the center for devices and radiological health (cdrh) of the food and drug administration (fda) and updates its expected fda approval timeline

Fort lauderdale, fla., sept. 11, 2024 (globe newswire) -- ss innovations international, inc. (the “company” or “ss innovations”) (otc: ssii), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update on its progress and timeline in obtaining u.s. food and drug administration (“fda”) approvals to market the ssi mantra surgical robotic system (“ssi mantra”) in the united states.
SSII Ratings Summary
SSII Quant Ranking